174 related articles for article (PubMed ID: 25684733)
1. Designer steroids - over-the-counter supplements and their androgenic component: review of an increasing problem.
Rahnema CD; Crosnoe LE; Kim ED
Andrology; 2015 Mar; 3(2):150-5. PubMed ID: 25684733
[TBL] [Abstract][Full Text] [Related]
2. Factors predicting normalization of reproductive hormones after cessation of anabolic-androgenic steroids in men: a single center retrospective study.
Grant B; Campbell J; Pradeep A; Burns AD; Bassett P; Abbara A; Saket P; Minhas S; Dhillo WS; McVeigh J; Bhasin S; Jayasena CN
Eur J Endocrinol; 2023 Dec; 189(6):601-610. PubMed ID: 38102386
[TBL] [Abstract][Full Text] [Related]
3. Anabolic-androgenic steroids: How do they work and what are the risks?
Bond P; Smit DL; de Ronde W
Front Endocrinol (Lausanne); 2022; 13():1059473. PubMed ID: 36644692
[TBL] [Abstract][Full Text] [Related]
4. Recovery of spermatogenesis after androgenic anabolic steroids abuse in men. A systematic review of the literature.
Rajmil O; Moreno-Sepulveda J
Actas Urol Esp (Engl Ed); 2024 Mar; 48(2):116-124. PubMed ID: 37567343
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of the Online Market for Anabolic-Androgenic Steroids in Central Asia: A Netnographic Analysis.
Nyssanbayeva K; Abdulla V; Semenova Y; Bakasheva M; Sagoe D; Glushkova N
Subst Use Misuse; 2024; 59(1):10-19. PubMed ID: 37724019
[TBL] [Abstract][Full Text] [Related]
6. [Collapsing Glomerulopathy Secondary to Anabolic Steroids for Bodybuilding: A Case Series].
Passaro R; D'AngiĆ² P; Laurino S; Gigliotti G; Massa A; Mancini A; Gonnella A; Giammarino A; Borriello G
G Ital Nefrol; 2023 Oct; 40(5):. PubMed ID: 38010246
[TBL] [Abstract][Full Text] [Related]
7. Cholestatic Jaundice With the Use of Methylstenbolone and Dymethazine, Designer Steroids Found in Super DMZ Rx 2.0 "Nutritional Supplement": A Case Report.
Agbenyefia P; Arnold CA; Kirkpatrick R
J Investig Med High Impact Case Rep; 2014; 2(2):2324709614532800. PubMed ID: 26425606
[TBL] [Abstract][Full Text] [Related]
8. Anabolic androgenic steroid abuse in the United Kingdom: An update.
Mullen C; Whalley BJ; Schifano F; Baker JS
Br J Pharmacol; 2020 May; 177(10):2180-2198. PubMed ID: 31989581
[TBL] [Abstract][Full Text] [Related]
9. Cutaneous manifestations of misuse of androgenic anabolic steroids: A retrospective cohort study.
Heerfordt IM; Windfeld-Mathiasen J; Dalhoff KP; Mogensen M; Andersen JT; Horwitz H
J Am Acad Dermatol; 2024 May; 90(5):1047-1048. PubMed ID: 38215797
[No Abstract] [Full Text] [Related]
10. Social Media, Body Image and Resistance Training: Creating the Perfect 'Me' with Dietary Supplements, Anabolic Steroids and SARM's.
Hilkens L; Cruyff M; Woertman L; Benjamins J; Evers C
Sports Med Open; 2021 Nov; 7(1):81. PubMed ID: 34757466
[TBL] [Abstract][Full Text] [Related]
11. A review of recent evidence on androgen abuse from interviews with users.
Grant B; Minhas S; Jayasena CN
Curr Opin Endocrinol Diabetes Obes; 2023 Dec; 30(6):285-290. PubMed ID: 37646503
[TBL] [Abstract][Full Text] [Related]
12. Male Fertility After Androgenic Steroid Use: How Little We Know.
Anawalt BD
J Clin Endocrinol Metab; 2021 Jun; 106(7):e2813-e2815. PubMed ID: 33861859
[No Abstract] [Full Text] [Related]
13. Cholestasis Linked to Bodybuilding Supplements: Exploring the Risks of Contamination.
Matusak M; Aljabban J; Wirtz M; Agni R; Spengler E
Case Reports Hepatol; 2024; 2024():5112461. PubMed ID: 38826497
[TBL] [Abstract][Full Text] [Related]
14. The cost of seeking an edge: Recurrent renal infarction in setting of recreational use of anabolic steroids.
Colburn S; Childers WK; Chacon A; Swailes A; Ahmed FM; Sahi R
Ann Med Surg (Lond); 2017 Feb; 14():25-28. PubMed ID: 28127424
[TBL] [Abstract][Full Text] [Related]
15. Physical, psychological and biochemical recovery from anabolic steroid-induced hypogonadism: a scoping review.
Solanki P; Eu B; Smith J; Allan C; Lee K
Endocr Connect; 2023 Dec; 12(12):. PubMed ID: 37855241
[TBL] [Abstract][Full Text] [Related]
16. Hepatotoxicity due to dietary supplements: state-of-the-art, gaps and perspectives.
Rivero-Pino F; Casanova AG
Crit Rev Toxicol; 2023 Nov; 53(10):601-610. PubMed ID: 38062980
[TBL] [Abstract][Full Text] [Related]
17. Reduced Quality of Life in Former Androgen Users: An Evolving Public-Health Concern.
Pope HG; Kanayama G
J Clin Endocrinol Metab; 2024 Apr; 109(5):e1400-e1401. PubMed ID: 37955864
[No Abstract] [Full Text] [Related]
18. AAS, growth hormone, and insulin abuse: psychological and neuroendocrine effects.
Graham MR; Evans P; Davies B; Baker JS
Ther Clin Risk Manag; 2008 Jun; 4(3):587-97. PubMed ID: 18827854
[TBL] [Abstract][Full Text] [Related]
19. The dichotomy between health and drug abuse in bodybuilding.
Horn J
Nordisk Alkohol Nark; 2024 Apr; 41(2):212-225. PubMed ID: 38645972
[No Abstract] [Full Text] [Related]
20. Psychiatric side effects of medications prescribed in internal medicine.
Casagrande Tango R
Dialogues Clin Neurosci; 2003 Jun; 5(2):155-65. PubMed ID: 22034468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]